ACAD
NASDAQ · Biotechnology
Acadia Pharmaceuticals Inc
$22.40
-0.16 (-0.71%)
Performance
1D
—
1W
—
1M
—
3M
-3.53%
6M
+0.90%
1Y
+28.44%
YTD
-14.80%
Open$22.43
Previous Close$22.56
Day High$22.91
Day Low$22.26
52W High$28.35
52W Low$14.45
Volume—
Avg Volume1.79M
Market Cap3.84B
P/E Ratio9.83
EPS$2.28
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$25.91
Below
SMA 200
$23.44
Below
RSI (14)
42.4
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
27 analysts
Price Target
-20.1% upside
Current
$22.40
$22.40
Target
$17.90
$17.90
$12.70
$17.90 avg
$23.84
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.08B | 950.20M | 1.03B |
| Net Income | 394.69M | 312.06M | 167.73M |
| Profit Margin | 36.5% | 34.7% | 16.3% |
| EBITDA | 109.07M | 91.03M | 233.13M |
| Free Cash Flow | — | — | 189.95M |
| Rev Growth | +13.8% | +13.8% | +10.0% |
| Debt/Equity | — | — | 0.91 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |